OncoSec is a late-stage biotechnology company developing immunotherapy cancer treatments using our plasmid DNA delivery platform. Through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. Our core technology platform continues to advance through clinical trials for various cancers. Our plasmid DNA delivery platform is designed to boost th...
OncoSec is a late-stage biotechnology company developing immunotherapy cancer treatments using our plasmid DNA delivery platform. Through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. Our core technology platform continues to advance through clinical trials for various cancers. Our plasmid DNA delivery platform is designed to boost the body’s immune system to target and attack cancer.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.